Alopecia Areata Drug Market Targets 2036 Expansion as Novel Therapies Enter Pipeline
The alopecia areata pharmaceutical market is set for substantial growth through 2036, driven by rising patient prevalence and the emergence of new drug classes including OX40L inhibitors. Novel therapies are reshaping treatment options and opening fresh opportunities across the healthcare sector. Investors are watching pipeline developments as the competitive landscape intensifies.
Salvado•